5-(3,4-Dimethoxyphenyl)-1,3-di(2-pyridyl)benzene HL14
3J(195Pt) 39, H6), 7.96 (2H, td, 3J 7.5, 4J 1.5, H4), 7.74 (2H, dd, 3J
8.0, 4J 1.5, H3), 7.61 (2H, s, H3¢), 7.50 (2H, d, 3J 8.5, Hb), 7.29 (6H,
m, Ha¢, H5), 7.16 (6H, m, Ha, Hb¢), 7.05 (2H, tt, 3J 7.0, 4J 1.0, Hc¢).
13C NMR (101 MHz, CDCl3): d 167.3, 152.5, 147.7, 147.3, 141.4,
139.3 (C4), 136.6, 135.8, 129.5, 127.7 (Cb), 124.5, 124.2, 123.5,
123.2 (Cc¢), 123.1 (C3¢), 119.4 (C3). Anal. Calcd. for C34H24N3PtCl:
C, 57.9; H, 3.4; N, 6.0%. Found C, 57.1; H, 3.4; N, 5.9%.
PtL11Cl From HL11 (81 mg, 0.15 mmol) giving a deep yellow
solid (25 mg, 22%). 1H NMR (400 MHz, CDCl3): d 9.38 (2H, d,
3J 6.0, J(195Pt) 40, H6), 7.96 (2H, td, 3J 7.5, 4J 1.5, H4), 7.75 (2H,
d, 3J 8.0, H3), 7.60 (2H, s, H3¢), 7.44 (2H, d, 3J 8.5, Hb), 7.29 (2H,
m, H5), 7.12 (4H, d, 3J 7.0, Hb¢), 7.03 (2H, d, Ha), 6.87 (4H, d, 3J
7.0, Ha¢). Anal. Calcd. for C34H24N3PtCl: C, 57.9; H, 3.4; N, 6.0%.
Found C, 57.1; H, 3.4; N, 5.9%.
Ligand HL14 was prepared as described for HL13, using 3,4-
dimethoxyphenylboronic acid (103 mg, 0.57 mmol) in place of
methoxyphenylboronic acid. Purification by chromatography on
silica gel, elution gradient from hexane to diethyl ether (Rf = 0.5 in
diethyl ether), yielded a colourless solid, which was recrystallised
from diethyl ether (64 mg, 31%). 1H NMR (500 MHz, CDCl3): d
3
4
4
8.75 (2H, d, J 4.5, H6), 8.55 (1H, t, J 1.5, H2¢), 8.27 (2H, d, J
1.5, H4¢), 7.92 (2H, d, 3J 8.0, H3), 7.82 (2H, td, 3J 7.5, 4J 1.5, H4),
7.31 (4H, m, H5, Hd, Hb), 6.98 (1H, d, J 8.0, Ha), 4.00 (3H, s,
3
m-CH3), 3.94 (3H, s, p-CH3). 13C NMR (126 MHz, CDCl3): d
157.3, 149.7 (C6), 149.2, 148.9, 142.3, 140.4, 137.0, 134.0, 126.2
(C4¢), 124.2 (C2¢), 122.5 (C5), 121.0 (C3), 119.9, 111.5 (Ca), 110.7,
56.2 (m-CH3), 56.1 (p-CH3). MS (ES+): m/z 369.3 [M + H]+.
PtL12Cl From HL12 (112 mg, 0.21 mmol) giving an orange solid
1
3
(100 mg, 68%). H NMR (500 MHz, CDCl3): d 9.28 (2H, d, J
5.6, J(195Pt) 36.5, H6), 7.91 (2H, t, 3J 7.5, H4), 7.69 (2H, d, 3J 7.5,
5-(3,4-Benzo-18-crown-6)-1,3-di(2-pyridyl)benzene HL15
H3), 7.51 (2H, s, H3¢), 7.46 (2H, d, J 8.5, Hb), 7.23 (2H, t, J
3
3
HL15 was prepared using the procedure used for HL10–12, starting
from dpyb-B (284 mg, 0.83 mmol), 4¢-bromobenzo-18-crown-6
(337 mg, 0.86 mmol), sodium carbonate (119 mg, 1.12 mmol),
and Pd(PPh3)4 (38 mg, 0.033 mmol) in a mixture of toluen◦e :
ethanol : water (6 : 6 : 1 mL). The mixture was heated at 80 C
for 80 h. Purification of the crude material by chromatography
on aluminium oxide, gradient elution from hexane to ethyl acetate
(Rf = 0.3 in ethyl acetate), yielded the product as a clear, colourless
oil (192 mg, 43%). 1H NMR (500 MHz, CDCl3): d 8.74 (2H, d, 3J
4.5, H6), 8.53 (1H, t, 4J 1.5, H2¢), 8.23 (2H, d, 4J 1.5, H4¢), 7.89 (2H,
6.5, H5), 6.74 (2H, d, J 8.5, Ha), 3.81 (4H, t, J 6.0, Hb), 3.71
(8H, m, Hg,e), 3.67 (8H, m, Ha,d). 13C NMR (126 MHz, CDCl3):
d 167.5, 159.7, 152.3, 147.0, 141.2, 139.1 (C4), 137.0, 129.1, 127.8
(Cb), 123.2 (C5), 122.6 (C3¢), 119.4 (C3), 111.9 (Ca), 71.5, 70.4, 70.3,
68.7 (Cb), 52.7 (Ca). MS (ES+): m/z 778.2 [M + Na+], 719.4 [M–
Cl]+. HRMS (ES+): 777.17832 [M + Na]+; [C32H34N3O4PtCl23Na]
requires 777.17778.
3
3
PtL13Cl From HL13 (48 mg, 0.14 mmol) giving a bright yellow
solid (55 mg, 72%). 1H NMR (500 MHz, CDCl3): d 9.33 (2H, d,
3J 5.5, J(195Pt) 40, H6), 7.94 (2H, t, 3J 8.0, H4), 7.73 (2H, d, 3J 7.5,
3
3
4
d, J 7.5, H3), 7.79 (2H, td, J 7.5, J 1.5, H4), 7.28 (4H, m, Hb,
Hd, H5), 6.98 (1H, d, 3J 8.0, Ha), 4.28 (2H, t, 3J 4.5, Ha¢), 4.22 (2H,
t, 3J 4.5, Ha), 3.96 (4H, t, 3J 4.5, Hb, Hb¢), 3.80 (4H, m, Hg , Hg¢),
3.74 (4H, m, Hd, Hd¢), 3.70 (4H, s, He, He¢). 13C NMR (126 MHz,
CDCl3): d 157.4, 149.8, 149.3, 149.0, 142.2, 140.5, 137.0, 134.6,
126.3 (C4¢), 124.2 (C2¢), 122.5 (C5), 121.1 (C3), 120.6, 114.5 (Cb),
113.9 (Cd), 71.0, 71.0, 70.9, 69.9, 69.8, 69.6, 69.4. HRMS (ES+):
m/z 543.24895 [M + H]+, [C32H35N2O6] requires 543.24896; m/z
565.23048 [M + Na]+, [C32H34O6N223Na] requires 565.23090.
H3), 7.56 (2H, s, H3¢), 7.55 (2H, m, Hb), 7.27 (2H, t, J 6.0, H5),
3
7.07 (2H, d, 3J 8.0, Ha), 3.88 (3H, s, CH3). 13C NMR (126 MHz,
CDCl3): d 167.4, 160.2, 159.2, 152.5 (C6), 141.3, 139.2 (C4), 136.7,
134.5, 128.1 (Cb), 123.4 (C5), 123.2 (C3¢), 119.5 (C3), 114.5 (Ca),
55.6 (CH3). Anal. Calcd. for C23H17N2OPtCl.1/4CH2Cl2: C 47.4,
H 3.0, N 4.8%. Found: C 47.9, H 2.9, N 4.8%.
PtL14Cl From HL14 (64 mg, 0.17 mmol) giving a yellow solid
(64 mg, 65%). 1H NMR (500 MHz, CDCl3): d 9.28 (2H, d, 3J 5.5,
3
4
3
J(195Pt) 40, H6), 7.92 (2H, td, J 7.5, J 1.0, H4), 7.72 (2H, d, J
8.0, H3), 7.52 (2H, s, H3¢), 7.23 (2H, ddd, 3J 7.0, 3J 6.0, 4J 1.0, H5),
7.16 (2H, m, Hb, Hd), 6.97 (1H, d, 3J 8.7, Ha), 4.01 (3H, s, m-CH3),
3.96 (3H, s, p-CH3). 13C NMR (126 MHz, CDCl3): d 167.2, 160.4,
152.4 (C6), 149.5, 148.7, 141.2, 139.1 (C4), 136.8, 135.0, 123.3 (C5),
123.3 (C3¢), 119.5 (C3), 119.4 (Cb), 111.7 (Ca), 110.5 (Cd), 56.4 (m-
CH3), 56.2 (p-CH3). Anal. calcd for C24H19N2O2PtCl.1/4CH2Cl2:
C, 45.3; H, 3.1; N, 4.3. Found: C, 45.1; H, 3.3; N, 4.2%.
Platinum complexes
The platinum(II) complexes of the ligands were prepared by
reaction with potassium tetrachloroplatinate(II) using one of two
methods. For Pt10–11Cl and Pt13–14Cl, a mixture of the ligand (50–
100 mg) and K2PtCl4 (1 equiv.) in acetic acid (typically 3 mL) was
degassed by three freeze–pump–thaw cycles and back-filled with
nitrogen gas. The mixture was refluxed for 72 h. The resulting
yellow or orange precipitate was separated by centrifugation and
washed successively with water, ethanol and diethyl ether (3 ¥
5 mL of each). The solid was then extracted into dichloromethane,
filtered to remove small amounts of insoluble residue, and the
solvent then evaporated to give the product. The complexes PtL9Cl
and Pt12Cl, which feature basic nitrogen atoms in the pendants, as
well as Pt15Cl, were prepared by mixing a solution of the ligand in
acetonitrile (typically 50 mg in 5 mL) with a solution of K2PtCl4
in water (1 equiv. in 2.5 mL), both of which had been previously
purged with nitrogen gas, and refluxing the mixture under nitrogen
for 72 h. Work-up was similar to that used for the preparations in
acetic acid.
PtL15Cl From HL15 (84 mg, 0.16 mmol) giving a yellow solid
(33 mg, 28%). 1H NMR (400 MHz, CDCl3): d 9.31 (2H, d, 3J 5.7,
3
4
3
J(195Pt) 40, H6), 7.94 (2H, td, J 7.5, J 1.5, H4), 7.72 (2H, d, J
8.0, H3), 7.53 (2H, s, H3¢), 7.26 (2H, m, H5), 7.16 (1H, s, Hd), 7.15
(1H, m, Hb), 6.97 (1H, d, 3J 8.5, Ha), 4.29 (1H, t, 3J 4.5, Ha¢), 4.23
(1H, t, J 4.5, Ha), 3.98 (2H, m, Hb, Hb¢), 3.81 (2H, m, Hg , Hg¢),
3
3.75 (2H, m, Hd, Hd¢), 3.71 (2H, s, He, He¢). MS (ES+): m/z 794.2
[M + Na]+, m/z 768.3 [M–Cl + MeOH]+.
Electrochemical measurements
Cyclic voltammetry was carried out using a mAutolab Type III
potentiostat with computer control and data storage via GPES
Manager software. Solutions of concentration 1 mM in 90%
CH3CN/10% CH2Cl2 were used, containing [Bu4N][BF4] as the
PtL10Cl From HL10 (76 mg, 0.16 mmol) giving a yellow solid
(97 mg, 88%). 1H NMR (400 MHz, CDCl3): d 9.35 (2H, d, 3J 5.5,
This journal is
The Royal Society of Chemistry 2009
Dalton Trans., 2009, 1728–1741 | 1739
©